Kenvue reported revenue of $15.1 billion for fiscal year 2025 (the twelve months to 28 Dec 2025), down 2.1% from fiscal 2024. Net income was $1.47 billion and diluted earnings per share $0.76.
In its latest reported quarter, the third quarter of fiscal 2026 (the three months to 27 Sep 2026), revenue was $3.89 billion, up 3.2% from a year earlier.
Figures from Kenvue's annual and quarterly reports, compiled and checked by AapWire. Latest report filed 30 Oct 2026.
Against Consumer Staples
Profitability
Lower half
Return on invested capital 8.2%, five-year average · 14th of 20
Balance sheet
Upper half
Net debt 2.2× EBITDA · 7th of 18
Among the sector's S&P 500 members with the figure; the longer the bar, the better placed. Debt and P/E rank lower first.
Revenue FY2025
$15.12B−2.1%
Net income
$1.47B+42.7%
Diluted EPS
$0.76+40.7%
Gross margin
58.1%+0.2 pts
Free cash flow
$1.72B+29.0%
Net debt
$7.61B−0.5%
Fiscal 2025 against fiscal 2024; bars show the last 5 fiscal years; net debt is borrowings and operating lease liabilities less cash and short-term investments at the year end.
Market value and moves at the latest close. Revenue growth compares the last twelve months with the twelve before; net margin and P/E over the last twelve months; P/E is left blank where earnings are negative.
Fiscal years, as the company cuts its revenue in its annual reports; the change on a year under each figure. A change is left out from a loss, from a sliver of revenue, or across a change in how the company reports.
By segment
Kenvue revenue by segment, by fiscal year
Revenue
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Self Care
$5.64B
$6.03B+6.9%
$6.45B+7.0%
$6.53B+1.2%
$6.38B−2.3%
Essential Health
$4.87B
$4.57B−6.2%
$4.62B+1.0%
$4.69B+1.6%
$4.63B−1.2%
Skin Health and Beauty
$4.54B
$4.35B−4.2%
$4.38B+0.6%
$4.24B−3.2%
$4.11B−3.0%
Total revenue
$15.05B
$14.95B
$15.44B
$15.46B
$15.12B
By region
Kenvue revenue by region, by fiscal year
Revenue
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
North America
$7.28B
$7.42B+1.8%
$7.61B+2.6%
$7.58B−0.4%
$7.26B−4.2%
Europe, Middle East, and Africa
$3.44B
$3.19B−7.2%
$3.39B+6.3%
$3.56B+5.0%
$3.72B+4.6%
Asia-Pacific
$3.28B
$3.15B−4.0%
$3.11B−1.2%
$2.97B−4.3%
$2.77B−6.7%
Latin America
$1.06B
$1.20B+13.2%
$1.34B+11.8%
$1.34B+0.3%
$1.37B+1.9%
Total revenue
$15.05B
$14.95B
$15.44B
$15.46B
$15.12B
Financial statements
Fiscal years, the latest ending 28 Dec 2025. Amounts in USD. On a narrow screen the table opens on the latest year and scrolls back.
Income statement
Kenvue income statement, annual
Period
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Revenue
$15.05B
$14.95B
$15.44B
$15.46B
$15.12B
Revenue growth
—
−0.7%
+3.3%
+0.1%
−2.1%
Gross profit
$8.42B
$8.29B
$8.64B
$8.96B
$8.79B
Operating income
$2.92B
$2.67B
$2.51B
$1.84B
$2.41B
Net income
$2.08B
$2.06B
$1.66B
$1.03B
$1.47B
Diluted EPS
$1.21
$1.20
$0.90
$0.54
$0.76
Gross margin
55.9%
55.4%
56.0%
58.0%
58.1%
Operating margin
19.4%
17.9%
16.3%
11.9%
16.0%
Net margin
13.8%
13.8%
10.8%
6.7%
9.7%
Cash flow
Kenvue cash flow, annual
Period
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Operating cash flow
$334.0M
$2.52B
$3.17B
$1.77B
$2.20B
Capital expenditure
$295.0M
$375.0M
$469.0M
$434.0M
$475.0M
Free cash flow
$39.00M
$2.15B
$2.70B
$1.33B
$1.72B
Balance sheet and shares
Kenvue balance sheet and shares, annual
Period
FY 2021
FY 2022
FY 2023
FY 2024
FY 2025
Cash and equivalents
$740.0M
$1.23B
$1.38B
$1.07B
$1.06B
Total debt
—
$116.0M
$8.43B
$8.72B
$8.67B
Shareholders' equity
$20.49B
$19.97B
$11.21B
$9.67B
$10.77B
Diluted shares
1.7B
1.7B
1.9B
1.9B
1.9B
Dividends per share
—
—
$0.40
$0.81
$0.82
Quarterly figures
The last eight fiscal quarters, the latest ending 27 Sep 2026. Year-on-year growth compares the same quarter of the previous fiscal year.
Kenvue quarterly financial figures
Period
Q4 FY2024
Q1 FY2025
Q2 FY2025
Q3 FY2025
Q4 FY2025
Q1 FY2026
Q2 FY2026
Q3 FY2026
Revenue
$3.66B
$3.74B
$3.84B
$3.76B
$3.78B
$3.91B
$3.96B
$3.89B
Revenue, year on year
−0.1%
−3.9%
−4.0%
−3.5%
+3.2%
+4.5%
+3.0%
+3.2%
Gross margin
56.5%
58.0%
58.9%
59.1%
56.5%
58.9%
58.2%
59.5%
Operating income
$483.0M
$558.0M
$692.0M
$629.0M
$535.0M
$767.0M
$699.0M
$706.0M
Net income
$293.0M
$322.0M
$420.0M
$398.0M
$330.0M
$474.0M
$456.0M
$430.0M
Diluted EPS
$0.15
$0.17
$0.22
$0.21
$0.17
$0.25
$0.24
$0.22
Free cash flow
$661.0M
$249.0M
$533.0M
$196.0M
$744.0M
$350.0M
$624.0M
$620.0M
Operating KPIs
The operating figures Kenvue reports beside its statements, then its revenue by product, segment and region, latest period first. Each links to its full history.
Each period is read from the report the company filed and checked against accounting identities before it is shown; a figure that does not pass is left blank rather than estimated. Free cash flow is operating cash flow less capital expenditure. Fiscal years follow the company's own calendar. See data and methodology.
$15.1 billion for fiscal year 2025 (the twelve months to 28 Dec 2025), as reported in its annual report.
What was Kenvue's net income in fiscal 2025?
$1.47 billion for fiscal year 2025 (the twelve months to 28 Dec 2025).
What were Kenvue's diluted earnings per share in fiscal 2025?
$0.76 for fiscal year 2025 (the twelve months to 28 Dec 2025).
What is Kenvue's gross margin?
58.1% for fiscal year 2025 (the twelve months to 28 Dec 2025): gross profit divided by revenue.
What is Kenvue's operating margin?
16.0% for fiscal year 2025 (the twelve months to 28 Dec 2025): operating income divided by revenue.
How much free cash flow did Kenvue generate in fiscal 2025?
$1.72 billion for fiscal year 2025 (the twelve months to 28 Dec 2025): operating cash flow less capital expenditure.
Where does Kenvue's revenue come from?
In fiscal 2025, by segment: Self Care $6.38B (42%), Essential Health $4.63B (31%), Skin Health and Beauty $4.11B (27%), out of $15.12B in all, as stated in its annual report.
In the terminal
Twenty years of Kenvue's figures, KPIs, guidance and a cash-flow valuation.
Every report line and operating figure, quarter by quarter